Welcome to our dedicated page for Delek Us Hldgs SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Delek US Holdings, Inc. (NYSE: DK) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. Delek US uses Form 8-K filings to furnish quarterly earnings releases, dividend announcements, investor presentations, and earnings call slides, giving investors a structured view of its financial condition and strategic messaging.
Through Item 2.02 of Form 8-K, Delek US reports results of operations and financial condition, including net income or loss, Adjusted net income, Adjusted EBITDA, and segment-level performance for refining and logistics. These filings often reference non-GAAP measures such as refining margin, adjusted refining margin, refining production margin, and net debt, along with reconciliations to GAAP metrics described in accompanying tables.
Item 7.01 Regulation FD disclosures in Delek US 8-Ks typically include earnings call slides and investor presentations. The company notes that these materials are furnished, not filed, and may be used in presentations to existing and prospective investors. Item 8.01 is used for other events, such as Board-approved quarterly dividends per share, with details on record and payment dates.
On this page, Stock Titan’s AI summarizes the key points from each filing so users can quickly understand what changed in Delek US’s business, capital allocation, and midstream relationship with Delek Logistics Partners, LP. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while AI-generated highlights help clarify complex sections, such as non-GAAP definitions and regulatory language, without replacing the need to review the full original documents.
Ezra Uzi Yemin and affiliated Yemin Investments LP reported sales of Common stock. The filing shows Yemin Investments LP sold 66,511 shares on 03/04/2026 and Ezra Uzi Yemin sold 18,139 shares on 03/04/2026. The transactions are reported on a Form 144 as transfers of previously acquired compensation shares.
DK reports insider sales of Common Stock by Yemin-related holders. The filing shows Yemin Investments LP sold 66,511 shares and Ezra Uzi Yemin sold 18,139 shares, both reported as sold on 03/04/2026. The transactions are reported on Form 144 and reflect dispositions of issuer common stock.
DK filing a Section 144 notice indicating 5,000 common shares are to be sold. The filing lists the broker Morgan Stanley Smith Barney LLC and identifies the securities as restricted stock units dated 03/10/2019.
It also discloses a recent sale of 5,392 shares on 03/04/2026 for $230,508.00.
Delek US Holdings EVP Denise Clark McWatters reported an open-market sale of 11,988 shares of common stock at $41.33 per share. After this transaction, she directly holds 74,196 shares of Delek US Holdings common stock, indicating she retains a substantial ongoing equity stake in the company.
DK submitted a Form 144 notice disclosing planned sales of restricted common stock that vested on multiple dates in 2022–2024. The notice lists broker Fidelity Brokerage Services LLC and vesting line items including 06/10/2022 (489 shares) and 09/10/2022 (1,935 shares).
Delek US Holdings EVP Robert G. Wright reported routine equity compensation activity. On March 10, 2026, he acquired 12,934 shares of common stock at no cost upon vesting of performance-based restricted stock units and received a separate grant of 3,075 time-vesting restricted stock units that vest over three years.
On the same date, 9,562 shares were withheld at a price of $40.64 per share to cover tax obligations related to these equity awards, rather than being sold on the open market. After these transactions, Wright directly owned 58,868 shares of Delek US Holdings common stock.
Spiegel Reuven reported acquisition or exercise transactions in this Form 4 filing.
Delek US Holdings EVP, Special Projects Reuven Spiegel received a grant of 9,842 shares of common stock as a time-vesting restricted stock unit award that vests over three years. After this compensation-related grant, his direct holdings increased to 58,372 common shares.
Delek US Holdings director Zohar Shlomo sold 5,000 shares of common stock in an open-market transaction at a price of $41.465 per share.
After this sale, Shlomo directly holds 13,989 shares of Delek US Holdings common stock, according to the latest ownership figures reported.
Delek US Holdings President & CEO Avigal Soreq reported multiple equity award transactions in common stock. On March 9 and 10, 2026, he acquired 95,249 shares through grants and vesting of restricted stock units, including performance-based awards and a new grant that vests over three years.
Across the same dates, 31,631 shares were disposed of at prices of $40.13 and $40.64 per share to cover tax obligations upon vesting of equity awards. After these transactions, Soreq directly holds 315,296 shares of Delek US Holdings common stock, indicating these are routine compensation-related grants and tax withholdings rather than open-market trades.
Delek US Holdings EVP and General Counsel Denise Clark McWatters reported routine equity compensation activity in company stock. On March 9 and 10, she received grants totaling 13,513 shares of common stock at no cost upon vesting of performance-based restricted stock units. In connection with these vestings, 11,606 shares were automatically withheld to cover tax obligations at prices of $40.13 and $40.64 per share, rather than sold on the open market. After these transactions, she directly holds 86,184 shares of Delek US Holdings common stock.